World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
71
Citations
64116
World Ranking
19913
National Ranking
9916

John H. Bond publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John H. Bond sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 244 publications — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John H. Bond D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John H. Bond sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 71 D-Index — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

John H. Bond was affiliated with the Veterans Health Administration in the United States. Their research focused primarily on medicine with additional involvement in biochemistry, genetics, and molecular biology.

The scientist's work covered several subfields including pulmonary and respiratory medicine, oncology, genetics, molecular biology, and cancer research. The main topics in their research explored advanced breast cancer therapies, chronic lymphocytic leukemia research, PI3K/AKT/mTOR signaling in cancer, cancer treatment and pharmacology, breast cancer treatment studies, estrogen and related hormone effects, and colorectal cancer screening and detection.

John H. Bond published research in various venues, with repeated contributions to these outlets:

  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • UNC Libraries

Frequent co-authors included Komal Jhaveri, Valentina Boni, Aditya Bardia, Peter Schmid, and Elgene Lim, each collaborating on multiple occasions.

Some of the recent publications attributed to John H. Bond were:

  • Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant Cancers, 2020, Clinical Cancer Research
  • Safety and activity of single-agent giredestrant (GDC-9545) from a phase Ia/b study in patients (pts) with estrogen receptor-positive (ER+), HER2-negative locally advanced/metastatic breast cancer (LA/mBC), 2021, Journal of Clinical Oncology
  • Evaluation of pharmacodynamic (PD) and biologic activity in a preoperative window-of-opportunity (WOO) study of giredestrant (GDC-9545) in postmenopausal patients (pts) with estrogen receptor-positive, HER2-negative (ER+/HER2-) operable breast cancer (BC), 2021, Journal of Clinical Oncology
  • Colorectal Cancer in Patients Under Close Colonoscopic Surveillance, 2021, UNC Libraries

Best Publications

  • Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.

    S J Winawer;A G Zauber;M N Ho;M J O'Brien

  • Guidelines for colonoscopy surveillance after polypectomy: A consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society

    Sidney J. Winawer;Ann G. Zauber;Robert H. Fletcher;Jonathon S. Stillman

  • Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.

    Bernard Levin;David A Lieberman;Beth McFarland;Kimberly S Andrews

  • Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood

    Mandel Js;Bond Jh;Church Tr;Snover Dc

  • Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths

    Ann G. Zauber;Sidney J. Winawer;Michael J. O'Brien;Iris Lansdorp-Vogelaar

  • COLORECTAL CANCER SCREENING AND SURVEILLANCE: CLINICAL GUIDELINES AND RATIONALE-UPDATE BASED ON NEW EVIDENCE

    Sidney Winawer;Robert Fletcher;Douglas Rex;John Bond

  • Colorectal cancer screening: Clinical guidelines and rationale

    SJ Winawer;RH Fletcher;L Miller;F Godlee

  • Use of Colonoscopy to Screen Asymptomatic Adults for Colorectal Cancer

    David A. Lieberman;David G. Weiss;John H. Bond;Dennis J. Ahnen

  • The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer

    Jack S. Mandel;Timothy R. Church;John H. Bond;Fred Ederer

  • A randomized trial of aspirin to prevent colorectal adenomas

    John A. Baron;Bernard F. Cole;Robert S. Sandler;Robert W. Haile

  • Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials

    Colin Baigent;N. Bhala;J. Emberson;A. Merhi

  • Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: Recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer

    Douglas K. Rex;John H. Bond;Sidney Winawer;Theodore R. Levin

  • Randomized Comparison of Surveillance Intervals after Colonoscopic Removal of Newly Diagnosed Adenomatous Polyps

    Winawer Sj;Zauber Ag;O'Brien Mj;Ho Mn

  • Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.

    Bernard F. Cole;John A. Baron;Robert S. Sandler;Robert W. Haile

  • Colorectal Cancer Mortality: Effectiveness of Biennial Screening for Fecal Occult Blood

    Jack S. Mandel;Timothy R. Church;Fred Ederer;John H. Bond

  • Calcium Supplements for the Prevention of Colorectal Adenomas

    Baron Ja;Beach M;Beach M;Mandel Js;van Stolk Ru

  • Long-term mortality after screening for colorectal cancer.

    Aasma Shaukat;Steven J. Mongin;Mindy S. Geisser;Frank A. Lederle

  • A Clinical Trial of Antioxidant Vitamins to Prevent Colorectal Adenoma

    E. Robert Greenberg;John A. Baron;Tor D. Tosteson;Daniel H. Freeman

  • Design and use of questionnaires: a review of best practice applicable to surveys of health service staff and patients

    E McColl;A Jacoby;L Thomas;J Soutter

  • A Comparison of Colonoscopy and Double-Contrast Barium Enema for Surveillance after Polypectomy

    Winawer Sj;Stewart Et;Zauber Ag;Bond Jh

Frequent Co-Authors

Sidney J. Winawer
Sidney J. Winawer Memorial Sloan Kettering Cancer Center
Michael Levitt
Michael Levitt Stanford University
Michael J. O'Brien
Michael J. O'Brien Tulane University
Timothy R. Church
Timothy R. Church University of Minnesota
Ann G. Zauber
Ann G. Zauber Memorial Sloan Kettering Cancer Center
Bernard Levin
Bernard Levin The University of Texas MD Anderson Cancer Center
John A. Baron
John A. Baron University of North Carolina at Chapel Hill
Dennis J. Ahnen
Dennis J. Ahnen University of Colorado Denver
Ian G. McKeith
Ian G. McKeith Newcastle University
Martin P Eccles
Martin P Eccles Newcastle University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers alongside or as an alternative to traditional medical school, there are several accessible online pathways to consider. Many students look to flexible options that fit their schedules, such as rn to bsn online no clinicals accredited programs, which allow registered nurses to earn a Bachelor of Science in Nursing degree completely online and without required clinical hours.

For nurses seeking advanced practice roles, short dnp programs can accelerate your path to a Doctor of Nursing Practice. Some may also wish to explore the easiest dnp programs, designed with flexible coursework and fewer barriers for experienced professionals.

Individuals eager to enter the nursing field quickly might benefit from lpn program options online. These fast-track programs can help you start your healthcare career in less time with the required licensure. Exploring these online degrees provides multiple paths into medicine and healthcare, meeting a wide range of career ambitions and educational backgrounds.

Best Scientists Citing John H. Bond

Recently Published Articles